Fox Chase Cancer Center

New technology spots drugs' early impact on cancer

A new preclinical technology enables researchers to quickly determine if a particular treatment is effective against gastrointestinal stromal tumors (GISTs), providing a boost to animal research and possibly patient care, ...

Apr 09, 2013
popularity not rated yet | comments 0

Quantifying heterogeneity in breast cancer

A variety of mutations may give rise to breast cancer, but scientists generally assume that it starts off with just a few. That's because later-stage breast cancers tend to have more mutations—they are more heterogeneous—than ...

Apr 09, 2013
popularity not rated yet | comments 0

New treatment holds promise for resistant lung cancer

A new chemotherapy regimen appears to produce minimal side effects in patients with lung cancer that has not responded to previous therapy, paving the way for additional research to determine if the new regimen also helps ...

Apr 09, 2013
popularity 5 / 5 (1) | comments 0

Exploring lincRNA's role in breast cancer

Once considered part of the "junk" of our genome, much of the DNA between protein-coding genes is now known to be transcribed. New findings by scientists at Fox Chase Cancer Center have identified several dozen transcripts ...

Apr 08, 2013
popularity not rated yet | comments 0

Scientists find a new way to boost common cancer drugs

Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue ...

Jan 14, 2013
popularity 5 / 5 (2) | comments 0 | with audio podcast

Protein tied to cancer drug resistance in mice

Blocking a specific protein renders tumors more vulnerable to treatment in mice, suggesting new therapies could eventually achieve the same in humans, according to new research from Fox Chase Cancer Center to be presented ...

Dec 07, 2012
popularity 5 / 5 (1) | comments 0 | with audio podcast